Agents in late-stage development for the treatment of osteoporosis and related bone disease.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Novo Nordisk Teams with Form Health, 9amHealth for Obesity Care
Read More
Lilly’s Oral GLP-1 Meets Endpoints in Phase 3 Trial
Employers: Cancer, GLP-1 Drugs and Mental Health Driving Healthcare Costs
FDA Approves First in Class Therapy for Hereditary Angioedema
MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar
FDA Set Review Date for Imcivree for Rare Form of Obesity